India’s two top lawyers will be arguing in the Singapore Court of Appeal the case of Japan’s Daiichi Sankyo Company and Ranbaxy Laboratories of India, according to a media report.
Ranbaxy has taken on senior advocate Harish Salve who is also the first non-Queen’s Counsel (QC) foreign lawyer, and the first from the Indian Bar, to be allowed to argue a case in the Singapore high court, The Straits Times reported on Tuesday.